This isn’t a fringe theory. In one clinical study that tracked COVID-19 survivors for six months, those who lost the most muscle mass during the acute illness were far more likely to still be fatigued: 76% of the high-muscle-loss group reported ongoing fatigue at six months, compared with 46% of those who lost comparatively little muscle<\/strong>. The weakness people describe as vague or unexplained often has a specific, physical driver underneath it \u2014 and it’s one that can be measured and tracked, not just described in words like “tired” or “off.”<\/p>\n Muscle loss during and after a significant viral illness isn’t mysterious once broken into its parts. Three overlapping mechanisms are at work, all well established in clinical literature generated during and after the COVID-19 pandemic \u2014 precisely because so many people went through significant illness at once.<\/p>\n Muscle is metabolically expensive tissue that the body actively maintains only when it is being used. Take away movement \u2014 through bed rest, hospitalisation, or simply being too unwell to be active \u2014 and muscle begins breaking down within days. Research on general bed rest and illness-related immobilisation has found declines of roughly 0.5\u20130.6% of muscle mass per day<\/strong>, with healthy young adults losing 1.7\u20134% of lower-limb muscle volume within just 2\u20135 days<\/strong>, and older adults losing as much as 5.5% in a single week<\/strong>. In hospitalised patients with more severe illness, the rate is faster still: a systematic review of 52 studies and over 3,200 critically ill patients found thigh muscle thickness declining by roughly 1.75\u20132.1% per day<\/strong> during the first week of critical illness, with nearly half of patients developing clinically significant weakness.<\/p>\n A significant viral illness also triggers a systemic inflammatory response that actively works against muscle maintenance. Research into post-COVID sarcopenia points to “anabolic resistance” \u2014 the body’s blunted ability to build and repair muscle in response to protein and movement, even once someone starts trying to rebuild. This is part of why recovery isn’t simply a matter of eating well and getting back to the gym \u2014 the body’s own muscle-building machinery is temporarily working against the person, not for them.<\/p>\n The more severe the illness, the worse the muscle picture tends to be. In a cohort of 530 people followed three months after moderate-to-severe COVID-19, 18.5% met criteria for sarcopenia overall \u2014 rising to 22.5% among those who needed invasive ventilation, versus 11.9% among those who didn’t<\/strong>. Low muscle mass was present in nearly a quarter of the group, and low muscle strength in close to half. Age above 60, obesity, and ventilation combined with a prolonged hospital stay were the strongest independent predictors \u2014 hospital stays for ventilated patients ran a median of 25 days, versus 9 days for the rest, and every extra day in bed adds to the deficit. This isn’t only a story about the sickest patients, though: adults recovering from mild-to-moderate<\/em>, non-hospitalised COVID-19 have also shown measurably reduced muscle strength on standard clinical scales \u2014 improving significantly with a structured two-week rehabilitation programme.<\/p>\n Here is the gap that causes so much confusion: medical “recovery” from a viral illness typically means the virus has cleared and acute symptoms \u2014 fever, cough, breathlessness at rest \u2014 have resolved. It’s a statement about the infection, not about your muscles. Functional and muscular recovery is a separate, slower process that standard post-illness follow-up rarely measures directly.<\/p>\n Most post-COVID medical follow-up in India understandably focuses on what caused hospitalisation in the first place: oxygen saturation, chest imaging, cardiac markers, blood counts. Skeletal muscle mass isn’t part of a routine check-up, and it’s rarely measured unless a patient is specifically referred into a rehabilitation programme. That gap matters, because the numbers suggest muscle loss is common rather than rare: sarcopenia has been documented in as many as 58% of patients entering post-COVID rehabilitation programmes<\/strong> in one hospital-based study, and a multi-centric Indian study following 315 patients across Vellore, Thiruvalla, Mumbai, and Hyderabad found 24% still reported at least one troubling symptom a full year after discharge<\/strong>, with muscle pain and weakness fluctuating throughout follow-up. A community-based study in rural Andhra Pradesh, surveying 500 survivors, found chronic fatigue affecting 21.4%<\/strong> \u2014 nearly 16 times more likely in those 60 and older, and nearly twice as common in women. None of these studies tracked muscle mass as the underlying cause; they tracked symptoms. The muscle loss driving many of those symptoms goes largely unmeasured in routine care.<\/p>\n “Do I feel tired” is a real signal, but an unreliable one to plan a recovery around \u2014 it’s shaped by sleep, mood, work stress, and motivation, not muscle status alone. Research has found muscle mass percentage is directly, negatively correlated with the severity of long COVID symptom scores: people with more preserved muscle mass tend to report fewer and milder ongoing symptoms. That’s exactly why an objective muscle measurement is useful alongside how someone feels, not instead of it.<\/p>\n This is where body composition tracking earns its place in a recovery plan \u2014 not as a diagnostic tool for long COVID itself, but as an objective marker of whether rehabilitation is working. In one structured six-week rehabilitation programme for post-COVID-19 syndrome, patients who completed physical training, education, and supervised exercise showed real, quantifiable change: skeletal muscle mass rose from an average of 23.2 kg to 24.2 kg, abdominal fat dropped, and six-minute walking distance improved from 320 metres to 382.5 metres. Those aren’t feelings \u2014 they’re numbers a patient, their doctor, and their physiotherapist could all look at together and agree the plan was working.<\/p>\n A bioelectrical impedance analysis (BIA) test \u2014 of the kind used in InBody testing \u2014 measures skeletal muscle mass directly, along with body fat and segmental distribution, in under five minutes. Repeated every few weeks through recovery, it gives a patient and their care team an objective trend line: is muscle mass climbing back toward baseline, holding steady, or still declining despite the person feeling “better”? That’s a complement to clinical judgement and physiotherapy assessment \u2014 not a replacement for either, and not a tool for diagnosing long COVID on its own.<\/p>\n None of the following replaces medical or physiotherapy guidance specific to your situation \u2014 especially after hospitalisation, or with underlying heart, lung, or metabolic conditions. Treat it as general orientation to discuss with your doctor or physiotherapist, not a self-directed plan.<\/p>\n It can be real and measurable, not just tiredness. Clinical studies have found sarcopenia (low muscle mass and strength) in 18\u201324% of patients three months after moderate-to-severe COVID-19, rising to as high as 58% among those entering post-COVID rehabilitation. The mechanism \u2014 inactivity during illness plus an inflammatory, muscle-catabolic state \u2014 is well documented.<\/p>\n<\/div>\n Yes. A study of adults recovering from mild-to-moderate, non-hospitalised COVID-19 found measurably reduced muscle strength on standard clinical scales, improving significantly with a structured two-week rehabilitation programme. Hospitalisation raises the risk and severity of muscle loss, but it isn’t required for meaningful weakness to develop.<\/p>\n<\/div>\n More than most expect. General bed rest research shows declines of roughly 0.5\u20130.6% of muscle mass per day, with healthy adults losing 1.7\u20134% of lower-limb muscle volume within 2\u20135 days and older adults up to 5.5% in a week. In hospitalised patients with severe illness, thigh muscle can decline around 1.75\u20132.1% per day in the first week.<\/p>\n<\/div>\n Because “recovered” medically means the virus has cleared and acute symptoms have resolved \u2014 not that your muscles have finished rebuilding. That’s a separate, slower process standard follow-up rarely measures directly. Research also shows people who lost more muscle during acute illness are considerably more likely to still be fatigued months later.<\/p>\n<\/div>\n The two appear connected. Research has found muscle mass percentage is negatively correlated with the severity of long COVID symptom scores. In one six-week rehabilitation programme, patients who rebuilt skeletal muscle mass also showed parallel improvement in walking capacity, fatigue, and breathlessness \u2014 suggesting the two are linked, not coincidental.<\/p>\n<\/div>\n It’s a reasonable, low-burden option to discuss with your doctor. A BIA-based test measures skeletal muscle mass directly in under five minutes and can be repeated every few weeks to show whether muscle is genuinely returning to baseline. It complements clinical and physiotherapy assessment \u2014 it does not diagnose long COVID or replace a doctor’s evaluation.<\/p>\n<\/div>\n It depends on how unwell you were. Structured rehabilitation has shown measurable strength gains within two weeks and meaningful muscle mass and walking-distance gains by six weeks. Recovery after hospitalisation with ventilation generally takes longer, given the larger starting deficit \u2014 a physiotherapist or doctor can help set a realistic timeline for your case.<\/p>\n<\/div>\n![\"InBody](\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/08\/inbody-770-clinical-analyzer.jpg\")
How a Viral Illness Turns Into Real, Measurable Muscle Loss<\/h2>\n
Inactivity and bed rest, which act faster than most people expect<\/h3>\n
Inflammation and “anabolic resistance”<\/h3>\n
Severity and hospitalisation compound the damage<\/h3>\n
Why “Recovered” Doesn’t Mean What Most People Assume<\/h2>\n
![\"InBody](\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/08\/inbody-970-clinical-analyzer.jpg\")
What Tracking Skeletal Muscle Mass Actually Adds<\/h2>\n
A Practical, General Approach to Post-Viral Recovery<\/h2>\n
\n
\nFrequently Asked Questions<\/h2>\n
Can COVID-19 really cause measurable muscle loss, or is post-COVID weakness just fatigue?<\/h3>\n
I wasn’t hospitalised for COVID-19 \u2014 can I still have lost muscle?<\/h3>\n
How much muscle can you actually lose from being sick in bed for a week or two?<\/h3>\n
Why do I still feel weak weeks after my COVID-19 test came back negative?<\/h3>\n
Does long COVID specifically affect muscle mass, or is that a separate issue?<\/h3>\n
Should I get a body composition test after a serious viral illness?<\/h3>\n
How long does it typically take to rebuild muscle lost during a serious illness?<\/h3>\n